Journal
AMERICAN JOURNAL OF THE MEDICAL SCIENCES
Volume 326, Issue 4, Pages 223-230Publisher
ELSEVIER SCIENCE INC
DOI: 10.1097/00000441-200310000-00014
Keywords
tobacco; nicotine; serious mental illness; craving; schizophrenia; treatment; program development
Categories
Funding
- NIDA NIH HHS [K-DA14009-01, R01-DA015537, R01-DA15978-01] Funding Source: Medline
- NIDDK NIH HHS [DK1-TI12549-01] Funding Source: Medline
Ask authors/readers for more resources
Tobacco addiction among persons with serious mental illness (SMI) has been largely ignored. About 75 to 85% of persons with schizophrenia, bipolar disorder, and other SMI use tobacco; most will either die and/or have reduced quality of life because of tobacco-caused medical diseases. Tobacco addiction is the most common co-occurring disorder for the SMI population. A dramatic reduction in tobacco use in the general population has occurred during the past 40 years; however, there has been almost no reduction for smokers with SMI. The University of Medicine and Dentistry of New Jersey program targets smokers with SMI and provides outreach services, clinical treatment and research, and consultation to other community-based mental health treatment agencies in New Jersey. Clinical and research evidence supports motivation-based treatment, blending mental health and addiction treatment approaches, and integrating tobacco dependence treatment within mental health settings. The unique barriers and clinical issues for this population are described.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available